화학공학소재연구정보센터
Journal of Industrial and Engineering Chemistry, Vol.75, 238-245, July, 2019
ROS-responsive thioether-based nanocarriers for efficient pro-oxidant cancer therapy
E-mail:
A high level of intracellular reactive oxygen species (ROS) is one of the remarkable intrinsic features of cancer cells. Therefore, ROS-responsive drug carriers have received great attention for cancer-selective drug delivery. In this study, ROS-responsive thioether-bearing polymers (TEP) were synthesized for effective intracellular delivery of piperlongumine (PL) into cancer cells. PL is a pro-oxidant drug that induces cytotoxic oxidative stress in cancer cells. PL-loaded TEP nanoparticles (PL-TEP NPs) were successfully formulated by a nanoemulsion method. PL-TEP NPs showed ROS-sensitive disassembly, which leads to ROS-sensitive drug release. In addition, PL-TEP NPs showed higher cytotoxicity in human breast cancer cells (MCF-7) than in normal human dermal fibroblast cells (hDFB), demonstrating their cancer cell-specific pro-oxidant therapy. This study demonstrates that ROS-responsive TEP NPs are effective drug carriers for efficient intracellular delivery of hydrophobic drug, PL.
  1. Fang J, Seki T, Maeda H, Adv. Drug Deliv. Rev., 61, 290 (2009)
  2. Kim J, Kim J, Bae JS, Exp. Mol. Med., 48, e269
  3. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB, Free Radic. Biol. Med., 49, 1603 (2010)
  4. Trachootham D, Alexandre J, Huang P, Nat. Rev. Drug Discov., 8, 579 (2009)
  5. Xu X, Saw PE, Tao W, Li Y, Ji X, Bhasin S, et al., Adv Mater., 29, 170014 (2017)
  6. Saravanakumar G, Kim J, Kim WJ, Adv. Sci., 4, 160012 (2017)
  7. Schumacker PT, Cancer Cell., 10, 175 (2006)
  8. Bezerra DP, Pessoa C, Moraes MO, Alencar NM, Mesquita RO, Lima MW, et al., J. Appl. Toxicol., 28, 599 (2008)
  9. Makhov P, Golovine K, Teper E, Kutikov A, Mehrazin R, Corcoran A, et al., Br. J. Cancer, 110, 899 (2014)
  10. Liu Y, Chang Y, Yang C, Sang Z, Yang T, Ang W, et al., Nanoscale, 6, 4325 (2014)
  11. Hong EJ, Lee DY, Kang HC, Kim YC, Shim MS, J. Ind. Eng. Chem., 63, 57 (2018)
  12. Torchilin VP, Adv. Drug Deliv. Rev., 64, 302 (2012)
  13. Moghimi SM, Hunter AC, Murray JC, Faseb J., 19, 311 (2005)
  14. Gismondi A, Reina G, Orlanducci S, Mizzoni F, Gay S, Terranova ML, Canini A, Biomaterials, 38, 22 (2015)
  15. Gismondi A, Nanni V, Reina G, Orlanducci S, Terranova ML, Canini A, Int. J. Nanomedicine, 11, 557 (2016)
  16. Jaiswal M, Dudhe R, Sharma PK, 3 Biotech., 5, 123 (2015)
  17. Chiang YT, Yen YW, Lo CL, Biomaterials, 61, 150 (2015)
  18. Hu P, Tirelli N, Bioconjugate Chem., 23, 438 (2012)
  19. McCall RL, Sirianni RW, J. Vis. Exp., 82, e51015 (2013)
  20. Kholdeeva OA, Kovaleva LA, Maksimovskaya RI, Maksimov GM, J. Mol. Catal. A-Chem., 158(1), 223 (2000)
  21. Xu Q, He C, Xiao C, Chen X, Macromol. Biosci., 16, 635 (2016)
  22. Nair DP, Podgo’rski M, Chatani S, Gong T, Xi W, Fenoli CR, Bowman CN, Chem. Mater., 26, 724 (2014)
  23. Kohane DS, Langer R, Chem. Sci., 1, 441 (2010)
  24. Roh JL, Kim EH, Park JY, Kim JW, Kwon M, Lee BH, Oncotarget, 5, 9227 (2014)